Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease.

Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease.

http://www.wikidata.org/entity/Q35803208

about

Development of an in-vivo active reversible butyrylcholinesterase inhibitor.Pharmacokinetics and pharmacodynamics of oral mecamylamine - development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulation.Graph Theory and Brain Connectivity in Alzheimer's Disease.Comparative Studies on Behavioral, Cognitive and Biomolecular Profiling of ICR, C57BL/6 and Its Sub-Strains Suitable for Scopolamine-Induced Amnesic Models.Neuroprotection of N-benzylcinnamide on scopolamine-induced cholinergic dysfunction in human SH-SY5Y neuroblastoma cells.The effects of AMPA receptor blockade on resting magnetoencephalography recordings.Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats.

P2860

Q37522451-6FDFC0B3-E518-4CFE-9752-095D6425F417 Q38786004-9AD281A5-F2AC-4C5C-B1FD-FD87179D2869 Q39239928-BEFA709C-2E8D-42D6-AE07-986270C65184 Q41573979-A996B48D-3523-47C1-98B7-381165C5DE9A Q46271187-4CB79731-8E84-42BC-848C-236E12C5BB1B Q47690097-BB3B9CD6-5CFD-44BF-B690-BBCE800430CB Q48663292-AFA0CD48-7D28-453E-A539-D48B0E85C79F

P2860

Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease.

http://www.wikidata.org/entity/Q35803208

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Scopolamine effects on functio ...... model of Alzheimer's disease.

@ast

Scopolamine effects on functio ...... model of Alzheimer's disease.

@en

type

label

Scopolamine effects on functio ...... model of Alzheimer's disease.

@ast

Scopolamine effects on functio ...... model of Alzheimer's disease.

@en

prefLabel

Scopolamine effects on functio ...... model of Alzheimer's disease.

@ast

Scopolamine effects on functio ...... model of Alzheimer's disease.

@en

P1433

Q35803208-D0C07C4C-4A0F-458D-A07B-EEBE3975128F

P1476

Q35803208-E322B930-BC42-44D2-BDB0-DE4629B7E40F

P2093

Q35803208-72075234-3B3D-4E05-975B-D81465B2B13F

Q35803208-78813305-EDD6-4C3E-9CF9-9AFB8F49C54C

Q35803208-AFD2F598-1CFD-4319-B24B-C646850E303F

Q35803208-F657465E-E1C9-4B06-A0B9-D2A13F49B709

P2860

Q35803208-02E15122-0389-4ACD-BA34-D0C147DC64AD

Q35803208-09016B47-F2B4-4212-8078-3EDD66482EE4

Q35803208-0A95F4ED-AD1C-4DFE-99E1-60C5ABF58A65

Q35803208-1BB5E888-79A7-43C9-8F3F-0D27D874C3FC

Q35803208-225C7155-7A4E-4A9D-9DB2-2134A65B1123

Q35803208-2867CEC4-D5F6-4BC0-81BF-8CDA7C600227

Q35803208-3C9D1DA7-362B-4462-99AD-3A3BC0D76A0D

Q35803208-437427BA-ACFB-4DA8-867D-F1B7F6E42A4C

Q35803208-4FBCE9D4-5EF6-4291-8ECF-2F9BEA49578A

Q35803208-5424D978-3DF6-416B-B6D3-7CEFE74433C7

P2888

Q35803208-0F08F4FB-6B26-475D-8732-FD1CEA6E1D14

P304

Q35803208-DB92207B-8DD2-4737-A5DC-617CFA2932CF

P31

Q35803208-CCA613D3-1FE6-4953-A1E3-F61AE41AEC21

P356

Q35803208-AA04EB7F-7105-4CB2-9A54-6CA72718DA6D

P407

Q35803208-1204DFC3-4568-430C-837A-2C18387F1470

P478

Q35803208-90820E7B-8FC7-447A-93A3-27841482E2F1

P50

Q35803208-2BFB56A6-F5FA-4616-A476-7AD105B39D02

Q35803208-8636ABC1-D693-42A4-8022-24DBC1D61FB8

Q35803208-C7A43AF0-245D-4CD4-AB06-DA7831101102

Q35803208-CC6B3C4B-EFF1-41AE-AA93-8A01E1CF2142

P577

Q35803208-77D05436-32A6-4AA1-A7DB-8F34F325F5A9

P5875

Q35803208-491B0DB4-C11B-44F1-AED0-23BD10F91413

P698

Q35803208-469C13C1-F008-4A0E-988C-00701AD3FD7C

P921

Q35803208-9C6A49F4-B3BF-4F4D-B626-059A1901CD5E

P932

Q35803208-8F7D10AC-B082-4393-B064-6EA0794A68CB

P356

P1433

Scientific Reports

P1476

Scopolamine effects on functio ...... l model of Alzheimer's disease

@en

P2093

D Osipova

http://www.w3.org/2001/XMLSchema#string

E Pekkonen

http://www.w3.org/2001/XMLSchema#string

E Pereda

http://www.w3.org/2001/XMLSchema#string

R Bajo

http://www.w3.org/2001/XMLSchema#string

P2860

Cochrane Database of Systematic Reviews

Scopolamine (hyoscine) for preventing and treating motion sickness

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

Collective dynamics of 'small-world' networks

Complex network measures of brain connectivity: uses and interpretations

Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers.

Efficiency and cost of economical brain functional networks.

Reorganization of functional networks in mild cognitive impairment.

Selecting forward models for MEG source-reconstruction using model-evidence

Organization, development and function of complex brain networks.

P2888

P304

9748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP09748

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

María E. López

Leonides Canuet

Fernando Maestú

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279528082

http://www.w3.org/2001/XMLSchema#string

P698

26130273

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4486953

http://www.w3.org/2001/XMLSchema#string